3Goldmann S,Stoltefuss J,Born L.Determination of the absolute configuration of the active amlodipine enantiomer as (-)-S:a correction.J Med Chem,1992,35:3341-3344.
4Laufen H,Leitold M.Enantioselective disposition of oral amlodipine in healthy volunteers.Chirality,1994,6:531-536.
5Kim SA,Park S,Chung N,et al.Efficacy and safety profiles of a new S (-)-amlodipine nicotinate formulation versus racemic anlodipine besylate in adult Korean patients with mild to moderate hypertension:an 8-week,multicenter,randomized,double-blind,double-dummy,parallel-group,phase Ⅲ,noninferiority clinical trial.Clin Ther,2008,30:845-857.
6Pathak L,Hiremath,Kerkar PG,et al.Multicentric,clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized,double-blind clinical trial.J Assoc Physicians India,2004,52:197-202.
7Thacker HP.S-amlodipine--the 2007 clinical review.J Indian Med Assoc,2007,105:180-182.